Roche’s Q3 sales down 3% on currency headwinds, drop in COVID sales

[ad_1] The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Acquire Licensing Rights Vabysmo eye drug beats consensus again…